PL370080A1 - Methods for preventing and treating bone loss with steroid compounds - Google Patents
Methods for preventing and treating bone loss with steroid compoundsInfo
- Publication number
- PL370080A1 PL370080A1 PL02370080A PL37008002A PL370080A1 PL 370080 A1 PL370080 A1 PL 370080A1 PL 02370080 A PL02370080 A PL 02370080A PL 37008002 A PL37008002 A PL 37008002A PL 370080 A1 PL370080 A1 PL 370080A1
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- methods
- bone loss
- treating bone
- steroid compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32820901P | 2001-10-10 | 2001-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370080A1 true PL370080A1 (en) | 2005-05-16 |
Family
ID=23279989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02370080A PL370080A1 (en) | 2001-10-10 | 2002-09-30 | Methods for preventing and treating bone loss with steroid compounds |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1435967A2 (en) |
| JP (1) | JP2005508958A (en) |
| KR (1) | KR20050032507A (en) |
| CN (1) | CN1713915A (en) |
| BR (1) | BR0213162A (en) |
| CA (1) | CA2463142A1 (en) |
| IL (1) | IL161162A0 (en) |
| MX (1) | MXPA04003405A (en) |
| NZ (1) | NZ532064A (en) |
| PL (1) | PL370080A1 (en) |
| WO (1) | WO2003032961A2 (en) |
| ZA (1) | ZA200402734B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040053900A1 (en) * | 1998-12-23 | 2004-03-18 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy |
| WO2005027916A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors |
| SG110107A1 (en) | 2003-09-24 | 2005-04-28 | Bioxell Spa | Compound and use in treatment |
| CA2605796A1 (en) * | 2005-04-25 | 2006-11-02 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| CN102939287B (en) | 2010-06-10 | 2016-01-27 | 塞拉根制药公司 | Estrogenic agents and uses thereof |
| US9193714B2 (en) | 2011-12-14 | 2015-11-24 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
| HUE063437T2 (en) | 2013-09-24 | 2024-01-28 | Fujifilm Corp | Pharmaceutical composition of a nitrogen-containing compound or salt thereof, or metal complex thereof |
| RU2729518C2 (en) | 2015-12-30 | 2020-08-07 | Сент-Луис Юниверсити | Meta-azacyclic aminobenzoic acid derivatives as pan-integrin antagonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8721384D0 (en) * | 1987-09-11 | 1987-10-21 | Erba Farmitalia | 17-substituted andro-sta-1 4-dien-3-one derivatives |
| GB2294879A (en) * | 1994-10-19 | 1996-05-15 | Merck & Co Inc | Cylcooxygenase-2 Inhibitors |
| US6590079B2 (en) * | 1997-01-30 | 2003-07-08 | Ixsys, Incorporated | Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same |
| ID28460A (en) * | 1998-07-08 | 2001-05-24 | Lipogenics Inc | COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL |
| EP1253966B1 (en) * | 1999-08-13 | 2011-04-27 | Curadis GmbH | Substances and agents for positively influencing collagen |
-
2002
- 2002-09-30 MX MXPA04003405A patent/MXPA04003405A/en unknown
- 2002-09-30 JP JP2003535765A patent/JP2005508958A/en active Pending
- 2002-09-30 NZ NZ532064A patent/NZ532064A/en unknown
- 2002-09-30 EP EP02801313A patent/EP1435967A2/en not_active Withdrawn
- 2002-09-30 KR KR1020047005231A patent/KR20050032507A/en not_active Application Discontinuation
- 2002-09-30 IL IL16116202A patent/IL161162A0/en unknown
- 2002-09-30 BR BR0213162-5A patent/BR0213162A/en not_active IP Right Cessation
- 2002-09-30 WO PCT/EP2002/011123 patent/WO2003032961A2/en not_active Application Discontinuation
- 2002-09-30 PL PL02370080A patent/PL370080A1/en not_active Application Discontinuation
- 2002-09-30 CA CA002463142A patent/CA2463142A1/en not_active Abandoned
- 2002-09-30 CN CNA028201167A patent/CN1713915A/en active Pending
-
2004
- 2004-04-07 ZA ZA200402734A patent/ZA200402734B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04003405A (en) | 2004-06-18 |
| BR0213162A (en) | 2004-09-14 |
| KR20050032507A (en) | 2005-04-07 |
| EP1435967A2 (en) | 2004-07-14 |
| IL161162A0 (en) | 2004-08-31 |
| ZA200402734B (en) | 2005-01-13 |
| CA2463142A1 (en) | 2003-04-24 |
| CN1713915A (en) | 2005-12-28 |
| WO2003032961A2 (en) | 2003-04-24 |
| WO2003032961A3 (en) | 2003-09-04 |
| JP2005508958A (en) | 2005-04-07 |
| NZ532064A (en) | 2006-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233205B (en) | Compounds for treating and preventing pre-eclampsia | |
| EP1411849A4 (en) | Apparatus and methods for treating tissue | |
| EP1217963A4 (en) | Devices and methods for treating tissue | |
| EP1446114A4 (en) | Compositions and methods for treating osteoporosis | |
| EP1416961A4 (en) | Composition and method for the treatment of disease | |
| EP1200086A4 (en) | Methods for treating or preventing pain and anxiety | |
| GB0110288D0 (en) | Composition and treatment method | |
| EP1361604A4 (en) | Device and method for treatment | |
| AU2002219945A1 (en) | Composition and method for treating snoring | |
| EP1446087A4 (en) | Method for treating non-neuropathic pain | |
| IL164219A0 (en) | Method for treating and preventing hyparathyroidism | |
| HU0200173D0 (en) | Method for preventing and treating skin aging | |
| EP1109548A4 (en) | Compositions and methods for treating and preventing bone diseases using tocotrienols | |
| EP1351647A4 (en) | Compositions and methods for treating hyperpigmentation | |
| GB2379761B (en) | System and method for appliance adaptation and evolution | |
| AU2002367023A8 (en) | Compositions and methods for treating heart failure | |
| IL161073A0 (en) | Composition and method for treating diabetes | |
| AU2002365057A8 (en) | Compositions and methods for treating heart failure | |
| IL161162A0 (en) | Methods for preventing and treating bone loss with steroid compounds | |
| HUP0401913A3 (en) | Medicine for preventing and treating bromhidrosis | |
| AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
| AU2006902A (en) | Methods and instruments for treating pseudoarthrosis | |
| AU2001218024A1 (en) | Methods for treating and preventing alopecia | |
| EP1253930A4 (en) | Method and compositions for treating hepatocellular cancer | |
| AU2002352925A8 (en) | Method for treating and preventing pancreatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |